Back to top

ESPR: HC Wainwright & Co. Reiterates Buy Rating with $16 Target | ESPR Stock News

ESPR: HC Wainwright & Co. Reiterates Buy Rating with $16 Target | ESPR Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Esperion Therapeutics, Inc. (ESPR)